Ulcerative Colitis. Ulcerative Colitis
Conditions
Interventions
training gluten free diet for one month.
Treatment - Other
training gluten free diet for one month
Sponsors
Vice Chancellor for research Urumia University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: inclusion criteria: being diagnosed with either mild or severe Ulcerative Colitis according to Up To Date 21-2 standard who are not in remission exclusion criteria: having a history of consuming Gluten Free Diet, using Aspirin or nonsteroidal anti-inflammatory drugs in the last few weeks of study, smoking or using drugs in the last 6 weeks and having celiac disease alongside UC (based on medical file or patient’s statements)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean Corpuscular Hemoglobin Concentration (MCHC). Timepoint: entering to the study,end of the washout period, end of the study. Method of measurement: ELISA.;Hemoglubolin. Timepoint: entering to the study,end of the washout period, end of the study. Method of measurement: ELISA.;Hematocrit. Timepoint: entering to the study,end of the washout period, end of the study. Method of measurement: ELISA.;Red Blood Cells. Timepoint: entering to the study,end of the washout period, end of the study. Method of measurement: ELISA.;Ferritin. Timepoint: entering to the study,end of the washout period, end of the study. Method of measurement: ELISA.;Serum Iron. Timepoint: entering to the study,end of the washout period, end of the study. Method of measurement: ELISA.;Total Iron-Binding Capacity (TIBC). Timepoint: entering to the study,end of the washout period, end of the study. Method of measurement: ELISA.;Mean Corpuscular Volume (MCV). Timepoint: entering to the study,end of the washout period, end of the study. Method of measurement: ELISA.;Mean Corpuscular Hemoglobin (MCH). Timepoint: entering to the study,end of the washout period, end of the study. Method of measurement: ELISA.;Red Cell size distribution Width (RDW). Timepoint: entering to the study,end of the washout period, end of the study. Method of measurement: ELISA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Anti-tissue Transglutaminase IgA antibodies (tTGA). Timepoint: entering to the study,end of the washout period, end of the study. Method of measurement: ELISA.;White Blood Cell (WBC). Timepoint: entering to the study,end of the washout period, end of the study. Method of measurement: ELISA.;Platelet. Timepoint: entering to the study,end of the washout period, end of the study. Method of measurement: ELISA.;Tumor Necrosis Factor alpha (TNF-alpha). Timepoint: entering to the study,end of the washout period, end of the study. Method of measurement: ELISA. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed